These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33441730)

  • 41. Comparison of interleukin IL-6 levels in the subretinal fluid and the vitreous during rhegmatogenous retinal detachment.
    Symeonidis C; Androudi S; Tsaousis KT; Tsinopoulos I; Brazitikos P; Diza E; Dimitrakos SA
    Cytokine; 2012 Jan; 57(1):17-8. PubMed ID: 22070971
    [No Abstract]   [Full Text] [Related]  

  • 42. Pathological vitreous causes cell line-derived (but not donor-derived) retinal pigment epithelial cells to display proliferative vitreoretinopathy-like features in culture.
    Sharma M; Tiwari A; Sharma S; Bansal R; Gupta V; Gupta A; Luthra-Guptasarma M
    Clin Exp Ophthalmol; 2014 Nov; 42(8):745-60. PubMed ID: 24612444
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Soluble cellular adhesion molecules in proliferative vitreoretinopathy and proliferative diabetic retinopathy.
    Barile GR; Chang SS; Park LS; Reppucci VS; Schiff WM; Schmidt AM
    Curr Eye Res; 1999 Sep; 19(3):219-27. PubMed ID: 10487959
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation.
    Snead DR; James S; Snead MP
    Eye (Lond); 2008 Oct; 22(10):1310-7. PubMed ID: 18344963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Apoptosis in proliferative vitreoretinopathy.
    El Ghrably I; Powe DG; Orr G; Fischer D; McIntosh R; Dua HS; Tighe PJ
    Invest Ophthalmol Vis Sci; 2004 May; 45(5):1473-9. PubMed ID: 15111604
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The current data on the proliferative process in diabetic retinopathy].
    Mazurina NK
    Vestn Oftalmol; 1999; 115(3):37-40. PubMed ID: 10432854
    [No Abstract]   [Full Text] [Related]  

  • 47. Correlation between miR-148 Expression in Vitreous and Severity of Rhegmatogenous Retinal Detachment.
    Tsunekawa T; Kaneko H; Takayama K; Hwang SJ; Oishi A; Nagasaka Y; Ye F; Iwase T; Nonobe N; Ueno S; Ito Y; Yasuda S; Matsuura T; Shimizu H; Suzumura A; Kataoka K; Terasaki H
    Biomed Res Int; 2017; 2017():3427319. PubMed ID: 28261609
    [No Abstract]   [Full Text] [Related]  

  • 48. Distinct Serum and Vitreous Inflammation-Related Factor Profiles in Patients with Proliferative Vitreoretinopathy.
    Ni Y; Qin Y; Huang Z; Liu F; Zhang S; Zhang Z
    Adv Ther; 2020 May; 37(5):2550-2559. PubMed ID: 32274748
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extent of Detached Retina and Lens Status Influence Intravitreal Protein Expression in Rhegmatogenous Retinal Detachment.
    Pollreisz A; Sacu S; Eibenberger K; Funk M; Kivaranovic D; Zlabinger GJ; Georgopoulos M; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5493-502. PubMed ID: 26284555
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
    Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
    Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of inflammatory mediators in patients with rhegmatogenous retinal detachment associated with choroidal detachment.
    Dai Y; Wu Z; Sheng H; Zhang Z; Yu M; Zhang Q
    Mol Vis; 2015; 21():417-27. PubMed ID: 26015767
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vitreous levels of oxidative stress biomarkers and the radical-scavenger α1-microglobulin/A1M in human rhegmatogenous retinal detachment.
    Cederlund M; Ghosh F; Arnér K; Andréasson S; Akerström B
    Graefes Arch Clin Exp Ophthalmol; 2013 Mar; 251(3):725-32. PubMed ID: 22829194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytokine profiling in the sub-silicone oil fluid after vitrectomy surgeries for refractory retinal diseases.
    Kaneko H; Takayama K; Asami T; Ito Y; Tsunekawa T; Iwase T; Funahashi Y; Ueno S; Nonobe N; Yasuda S; Suzumura A; Shimizu H; Kimoto R; Hwang SJ; Terasaki H
    Sci Rep; 2017 May; 7(1):2640. PubMed ID: 28572674
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retinal breaks in diabetic retinopathy: vitreoretinal relationships.
    Kakehashi A; Trempe CL; Fujio N; McMeel JW; Schepens CL
    Ophthalmic Surg; 1994; 25(10):695-9. PubMed ID: 7898863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rhegmatogenous retinal detachment in Labrador retrievers. II. Proliferative vitreoretinopathy.
    Blair NP; Dodge JT; Schmidt GM
    Arch Ophthalmol; 1985 Jun; 103(6):848-54. PubMed ID: 4004628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of connective tissue growth factor with fibrosis in vitreoretinal disorders in the human eye.
    Kuiper EJ; de Smet MD; van Meurs JC; Tan HS; Tanck MW; Oliver N; van Nieuwenhoven FA; Goldschmeding R; Schlingemann RO
    Arch Ophthalmol; 2006 Oct; 124(10):1457-62. PubMed ID: 17030714
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A sustained dual drug delivery system for proliferative vitreoretinopathy.
    Xiao Y; Choi KS; Warther D; Huffman K; Landeros S; Freeman WR; Sailor MJ; Cheng L
    Drug Deliv; 2020 Dec; 27(1):1461-1473. PubMed ID: 33100053
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Elevated adrenomedullin in the vitreous of patients with proliferative vitreoretinopathy.
    Udono T; Takahashi K; Takano S; Shibahara S; Tamai M
    Am J Ophthalmol; 1999 Dec; 128(6):765-7. PubMed ID: 10612519
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered Decorin Biology in Proliferative Vitreoretinopathy: A Mechanistic and Cohort Study.
    Begum G; O'Neill J; Chaudhary R; Blachford K; Snead DRJ; Berry M; Scott RAH; Logan A; Blanch RJ
    Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):4929-4936. PubMed ID: 30347087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.